Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2000
11/22/2000EP1054012A1 Purine derivatives and adenosine a2 receptor antagonists serving as preventives/remedies for diabetes
11/22/2000EP1054007A2 Method for the preparation of (+/-)-calanolide A
11/22/2000EP1054004A1 Novel pyrimidine-5-carboxamide derivatives
11/22/2000EP1053989A2 Hydroxydiphenyl ether compounds
11/22/2000EP1053749A1 Preventives and remedies for neuron digeneration-associated diseaseas
11/22/2000EP1053748A1 Remedies for neurological disorders
11/22/2000EP1053746A1 Use of biodegradable microspheres for the delivery of a anticancer agent for the treatment of glioblastoma
11/22/2000EP1053745A1 Use of at least a calcium-channel-inhibitor in the treatment of wrinkles
11/22/2000EP1053744A2 Substituted phenols as fragrance, flavor and antimicrobial compounds
11/22/2000EP1053351A1 Novel molecules of the tnf receptor superfamily and uses therefor
11/22/2000EP1053341A1 Use of negative regulation elements for nerve-specific expression of transgenes
11/22/2000EP1053332A1 Protein
11/22/2000EP1053316A1 Nucleic acids provided for modulating cellular activation
11/22/2000EP1053313A1 Optimized antisense oligonucleotides complementary to dna methyltransferase sequences
11/22/2000EP1053255A1 THREE-DIMENSIONAL STRUCTURES AND MODELS OF Fc RECEPTORS AND USES THEREOF
11/22/2000EP1053245A1 45 human secreted proteins
11/22/2000EP1053244A1 Glycosidation of 4,5-epoxymorphinan-6-ols
11/22/2000EP1053241A1 Novel dimerizing agents, their production and use
11/22/2000EP1053240A1 Glucocorticoid-selective antiinflammatory agents
11/22/2000EP1053239A1 Glucocorticoid-selective anti-inflammatory agents
11/22/2000EP1053238A1 Therapeutic compounds
11/22/2000EP1053236A1 Pyrdiyl-briidgehead derivatives and their analogues, pharmaceutical compositions and their use as inhibitors of nicotinic cholinergic receptors
11/22/2000EP1053235A1 Oxazole derivatives as serotonin-1a receptor agonists
11/22/2000EP1053234A1 Salts of paroxetine
11/22/2000EP1053233A1 Hydroxamic and carboxylic acid derivatives
11/22/2000EP1053230A1 Triazine antiviral compounds
11/22/2000EP1053227A1 Ppar-gamma modulators
11/22/2000EP1053226A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
11/22/2000EP1053224A1 Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
11/22/2000EP1053221A2 Lipid mixtures and their use
11/22/2000EP1053023A2 Systemic delivery of serum stable plasmid lipid particles for cancer therapy
11/22/2000EP1053022A2 Sensitizing cells to compounds using lipid-mediated gene and compound delivery
11/22/2000EP1053018A2 DELIVERY OF IMMUNOGENIC MOLECULES VIA HBsAg PARTICLES
11/22/2000EP1053012A1 Pharmaceutical compositions comprising peg-asparaginase for the treatment of hiv infections
11/22/2000EP1053008A2 Methods of inducing hair growth and coloration
11/22/2000EP1053007A2 Methods and compositions for modulating leptin activity
11/22/2000EP1053000A1 Agents and methods for protection, treatment and repair of connective tissue
11/22/2000EP1052999A1 Chelated 8-hydroxyquinoline for the treatment of epithelial lesions
11/22/2000EP1052998A1 Compositions and methods for modulating cytokine release in response to genotoxic agents
11/22/2000EP1052997A1 Compositions comprising d-chiro-inositol for treating metabolic diseases characterized by hyperinsulinemia, hyperandrogenism, hyperlipidemia and/or anovulation
11/22/2000EP1052996A1 Medicine for treating apoptosis dysfunction containing oligosaccharides
11/22/2000EP1052994A2 Use of dipeptidylpetidase inhibitors to regulate glucose metabolism
11/22/2000EP1052993A1 Combination of an alpha-adrenergic antagonist and a nitrogen oxide donor for treating female sexual dysfunction
11/22/2000EP1052992A1 Cyclic amine modulators of chemokine receptor activity
11/22/2000EP1052991A1 Use of loeramide forthe treatment of microbial infections
11/22/2000EP1052990A2 Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction
11/22/2000EP1052989A1 Use of 2-amino-6- trifluoromehthoxy- benzothiazole for preventing or treating cerebellum dysfunction
11/22/2000EP1052988A1 Methods and compositions for inactivating viruses
11/22/2000EP1052987A1 Tablets to be crunched or sucked, comprising iron as active principle
11/22/2000EP1052986A1 Anti-inflammatory agents
11/22/2000EP1052985A1 Pharmaceuticals comprising n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid for iron chelating therapy
11/22/2000EP1052984A1 Antibacterial agents
11/22/2000EP1052983A2 Use of an mao-a or mao-b inhibitor for the treatment of vascular disorders
11/22/2000EP1052982A1 AMINOTETRALINS AS 5-HT 1D$g(a)? AGONISTS
11/22/2000EP1052981A1 Fungal sulphur source and method of using the same
11/22/2000EP1052980A1 Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis
11/22/2000EP1052977A1 Treatment of chronic inflammatory disorders of the gastrointestinal tract
11/22/2000EP1052975A1 Propofol composition containing sulfite
11/22/2000EP1052974A2 Compositions containing organic compounds
11/22/2000EP1052973A1 Transmucosal formulations of levosimendan
11/22/2000EP1052967A2 Antiplaque oral composition and method
11/22/2000EP1052963A1 Compositions and methods of treating keratin-related disorders and conditions
11/22/2000EP0736012B1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations
11/22/2000EP0726267B1 Quinazoline derivatives
11/22/2000EP0725637B1 Parenteral busulfan for treatment of malignant disease
11/22/2000EP0722327B1 Improvements relating to antibacterial compositions
11/22/2000EP0720852B1 Remedy for nervous diseases
11/22/2000EP0705255B1 N-morpholino-n-nitrosaminoacetonitril cyclodextrin inclusion complexes
11/22/2000EP0703988B1 Mesothelial cell gene therapy
11/22/2000EP0701443B2 Terfenadine metabolites and their optically pure isomers for treating allergic disorders
11/22/2000EP0699180B1 Bicyclic amide derivatives and their use as muscle relaxants
11/22/2000EP0669936B1 Mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace
11/22/2000EP0666753B1 Use of peptides FOR THE TREATMENT OF THE COMPLICATIONS AND PATHOLOGY OF DIABETES
11/22/2000EP0663823B1 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
11/22/2000EP0639078B1 Use of silicone/fluorosilicone copolymer oil for the manufacture of a medicament for treating eye disorders
11/22/2000EP0586535B1 Methods and compositions based on inhibition of cell invasion and fibrosis by dextran sulfate
11/22/2000CN1274398A Resin-impregnated having texturized outer surface for application on papermaking machines
11/22/2000CN1274357A Antipsychotic substituted piperidine derivatives
11/22/2000CN1274354A Robustaflavone, intermediates and analogues and method for prepn. method
11/22/2000CN1274353A Halogen substituted tetracyclic tetrahydrofuran derivatives
11/22/2000CN1274350A Efficient method for conversion of nitriles to amidines
11/22/2000CN1274344A Novel vitamin D analogues
11/22/2000CN1274288A Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors
11/22/2000CN1274287A Compsn. and method of treating cancer with tannic acid and tannin complexes
11/22/2000CN1274286A Parenteral formulations comprising carbamazepine or its derivatives
11/22/2000CN1274284A Methods of modulating serine/threnoine protein kinase function with 5-azaquinoxaline-based compounds
11/22/2000CN1274283A Quinoline-containing & Alpha;-ketoamide cysteine and serine protease inhibitors
11/22/2000CN1274282A Treatment of diabetes with thiazolidinedione and Alpha-glucosidase inhibitor
11/22/2000CN1274281A Compsns. for treating and preventing arterial thrombosis and use of factor Xa inhibitor on its own and/or combined with platelet antiaggegating agent
11/22/2000CN1274280A Delayed total release gastrointestinal drug delivery system
11/22/2000CN1274279A Film-coated tablet for improved upper gastrointestinal tract safety
11/22/2000CN1273974A Camptothecin derviative, its prepn. method and medicinal compsns. containing same
11/22/2000CN1273967A Novel substituted dimeric compounds, its preparing process and medicinal compsns. containing same
11/22/2000CN1273966A Process for preparing adrenin beta-excitomotors by combinaion and disconnection method
11/22/2000CN1273861A Low sustituted ethylene-lactic cellulose and solid preparation
11/22/2000CN1273835A Chinese medicine for treating rheumatism
11/22/2000CN1273829A Medicinal composition for treating foot ringworm
11/22/2000CN1273826A Method for preventing by-effect of clamycin as injection
11/22/2000CN1273825A Medicine for treating diabetes, piles and nephritis and preparing process thereof
11/22/2000CN1273824A Exterior-applied medicine containing phosphonomycin calcium and its application
1 ... 6205 6206 6207 6208 6209 6210 6211 6212 6213 6214 6215 6216 6217 6218 6219 6220 6221 6222 6223 6224 6225 ... 7860